# Enanta Pharmaceuticals Inc: Form 8-K, filed Sep 29, 2025

- Company: [Enanta Pharmaceuticals Inc](/companies/enta.md) (CIK 1177648)
- Form: 8-K
- Filed: 2025-09-29
- Accepted by EDGAR: Sep 29, 2025, 08:20 ET
- Period: 2025-09-29
- Accession: 0001193125-25-221791
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1177648/000119312525221791/d65423d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1177648/000119312525221791/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1177648/000119312525221791/d65423d8k.htm

Filed Sep 29, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-221791. Last ingested by Listed: Oct 29, 2026, 16:06 ET. No prices; not investment advice.
